Cogent Biosciences, Inc. (COGT)
35.52
-1.60
(-4.31%)
USD |
NASDAQ |
Dec 31, 16:00
36.10
+0.58
(+1.63%)
After-Hours: 20:00
Cogent Biosciences Research and Development Expense (TTM): 251.67M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.13B |
| Ionis Pharmaceuticals, Inc. | 879.75M |
| Cidara Therapeutics, Inc. | 131.82M |
| Olema Pharmaceuticals, Inc. | 146.78M |
| ADMA Biologics, Inc. | 3.776M |